B5ZBI3 AF NFT

Leucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidnlpmxkmaudffuczhvdw33wrutgtguv6f2wc5bswn3shdwuq2g6m/metadata.json
IPFS of structure file: 
bafybeihcygwjad63kipezncflgo6f2upgk2zxry462i37fyhdczdf5p3r4/AF-B5ZBI3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xbff27Dc0a932A6E0d9Fe883AAbD1BF27bB95A69F
First NFT owner address (bech32): 
genesis1hle8ms9fx2nwpk073qa2h5dly7aetf5lctcm7h
Current NFT ID #450484 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
450484
Accession (UniProt):
B5ZBI3
Name::
Leucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Ureaplasma urealyticum serovar 10 (strain ATCC 33699 / Western)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B5ZBI3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B5ZBI3|SYL_UREU1 Leucine--tRNA ligase OS=Ureaplasma urealyticum serovar 10 (strain ATCC 33699 / Western) OX=565575 GN=leuS PE=3 SV=1 MYNHNKIEKKWQKYWLDNKTFKFVDNPNNPKKFYVLDMFPYPSGKGLHVGHPKGYTATDVISRFKRLNGYDVLHPIGWDAFGLPAEQYALETNNHPHTFTQQNIKIFRKQLQMIGFDFDYDKEVDTTDPQFYQWTQWIFVQLYKHNLAEIQDIDVNWCENLGTVLSNEEVVLNDKNERVSERGGHPVVRKPMKQWVLKIVDYADKLLDGLNEVEFSESLKSLQRNWIGKSIGTNVQFKIKDSHLALDVFTTRIDTIYGAQYLVVAPEHPILKSIVSEQQASVVQAYVDQTKKISDLDRIADTNKTGVFSGTYAINPINQEIIPIWVSDYVLMNFATGAVMGVPAHDERDYAFAKKYDLPIKSVIDTKQSLPYTGDGLHINSPMINGLNIEQSQNILNDYLVKNHLAKRVVNYKLRNWIFSRQRYWGEPFPVLFDENNQIKIIEDLPVLLPNLDEFKPSKTGESPLANAQEWLYVEIDGKKYRRETNTMPQWAGSSWYFLAYILKNEDGSYTPLNSEEAKKRFAKWLPVDVYIGGQEHAVLHLLYARFWHRFLYDIGVVPTKEPFYKVINQGMILGENNEKMSKSKGNVINPDDIIASHGADTLRIYEMFMGPLTASLPWSPDGLDAMRKWLDRVYRLYHNLSELEVVEDVNKLNEEIIITYHTLIKNYTKAINEQAFNIAISEMMVFVNVLYKNKVINYKLLDNFLILLSCFAPHLAEELYSLNHSESVCLQKMPIYDEQKIIAQNVTIPIQINGKLKHTINVLRDTNAEQLINLALACEQVKQAIGDQPIKKQIVVVNKIINFVI